Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing.

Autor:	Foley GR; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia., Marthick JR; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia., Ostrander EA; Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA., Stanford JL; Fred Hutchinson Cancer Center, 1100 Fairview Ave. N., M4-B874, Seattle, WA 98109-1024, USA., Dickinson JL; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia., FitzGerald LM; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7000, Australia. Electronic address: liesel.fitzgerald@utas.edu.au.
Jazyk:	angličtina
Zdroj:	European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Feb; Vol. 180, pp. 155-157. Date of Electronic Publication: 2022 Dec 10.
DOI:	10.1016/j.ejca.2022.11.034
Abstrakt:	Competing Interests: Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect